Entod Pharma is in the final stages of developing an eye drop that could be a relief for people (mostly over 40 years of age) affected by presbyopia, according to a company statement.
As per studies, the eye drop has been shown to improve close-up vision within 15 minutes, with one drop in each eye providing sharper vision for six to 10 hours.
Clinical studies carried out worldwide have also shown promising results including in the US, the statement claimed.
Nikkhil K Masurkar, CEO, Entod Pharma, informed, “Clinical trials for this eye drop have been conducted in the US by another company (the name of which can not be disclosed).
It has been approved by the US Food and Drug Administration (FDA), and is already in the market.
In India, Entod has redeveloped and optimized the formulation. We will be applying for the Drugs Controller General of India’s (DCGI) approval next month based on the studies that have been carried out in India, after which the trials will be conducted. “
The eye drop will be manufactured under the “Make-in-India” initiative, and launched across the country and worldwide at an affordable price, as per the statement.
Alpesh Chauhan, Senior Marketing Manager, stated in the statement, “PresVu eye drop has the potential to utilize the eye’s natural ability to reduce its pupil size, which, in turn, could expand the depth of field and focus, allowing a person to focus on different ranges naturally.”
Furthermore, it has the ability to rapidly adjust to the pH of the tears in the eyes through a dynamic buffer technology that makes it ideal for long-term use and safety.”
Ophthalmologist Dr. Rishi Swarup, Director, Swarup Eye Centre, Hyderabad, also said in the statement, “Clinical studies have shown that such eye drops work best in people between the ages of 40 and 55 years for mild-to-intermediate cases of presbyopia, thereby, temporarily correcting vision problems.”
It is important that such eye drops, once approved, should strictly be prescribed by an eye doctor after a thorough consultation and diagnosis of presbyopia.
Although, by no means a complete cure, these eye drops could prove to be a useful tool in the management of presbyopia, for which there is currently no medical treatment, except correction through reading glasses.
Govt introduces registration certificate for sales of Medical Devices
USFDA gives final approval for Brivaracetam tablets
Unichem recalls 18,960 bottles of this hypertension drug
Doctors urge FDA to add miscarriage management to abortion pill label
NPPA fixes Retail Prices of 40 Formulations: September 2022
USFDA tentative approves Amantadine extended-release capsules
API manufacturing finally getting the attention it deserves
IPC launches 1000th IP Reference Standard
NDPS: Inter-state Pharmaceutical drug racket busted
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
